Gain Therapeutics Stock (NASDAQ: GANX) stock price, news, charts, stock research, profile.
Open | $1.21 |
Close | $1.21 |
Volume / Avg. | 82.72K / 270.00K |
Day Range | 1.21 - 1.23 |
52 Wk Range | 1.11 - 5.33 |
Market Cap | $31.46M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 0.81% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Other companies in Gain Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuneering (NASDAQ:IMRX), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Longeveron (NASDAQ:LGVN).
There is no analysis for Gain Therapeutics.
Gain Therapeutics has a consensus price target of $8.00.
The stock price for Gain Therapeutics (NASDAQ: GANX) is $1.25 last updated July 19, 2024 at 9:22 AM EDT.
There are no upcoming dividends for Gain Therapeutics.
Gain Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Gain Therapeutics.
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.